The Wall Street Journal: First-ever digital drug gets FDA approval

U.S. authorities approved the world’s first digital drug, an antipsychotic pill that signals smartphones once it reaches the gut so doctors can track whether patients are taking their medication.

Tuesday’s green light from the Food and Drug Administration means Japan’s Otsuka Pharmaceutical Co. can implant a tiny chip containing minerals like silicon, magnesium and copper inside tablets of Abilify, which is used to treat schizophrenia, bipolar disorder and other mental illnesses.

Once swallowed, the chip mixes with stomach acids and sends a heartbeat-like signal to an adhesive patch worn on a patient’s torso. The patch records the dosage and time of ingestion and relays this to a smartphone app for patients to monitor and share with doctors and caretakers. The chip ultimately passes through the digestive tract normally.

Otsuka, whose parent company is Otsuka Holdings Co. Inc. 4578, +0.50%  , spent years testing the drug with Silicon Valley company Proteus Digital Health Inc., which provided the chip technology.

An expanded version of this report appears on WSJ.com.

Also popular on WSJ.com:

Surveillance cameras made by China are hanging all over the U.S.

Bitcoin plunges more than 25% over four days.

Filed in: Top News Tags: 

You might like:

MarketWatch First Take: An earnings double whammy may add fuel to the fire on Wall Street MarketWatch First Take: An earnings double whammy may add fuel to the fire on Wall Street
Brace yourself, these kinds of people are the most likely to get hacked Brace yourself, these kinds of people are the most likely to get hacked
Earnings Results: Micron stock tanks as sales outlook falls well short of target, production growth slashed Earnings Results: Micron stock tanks as sales outlook falls well short of target, production growth slashed
Personal Finance Daily: It’s still possible to give to charity and save on your taxes and Americans have high expectations for discounts Personal Finance Daily: It’s still possible to give to charity and save on your taxes and Americans have high expectations for discounts
The Wall Street Journal: Former Disney exec may be CBS’s top candidate for new CEO The Wall Street Journal: Former Disney exec may be CBS’s top candidate for new CEO
Market Extra: Bond market’s inflation gauge slides to lowest since Oct. 2017 as Fed meeting gets underway Market Extra: Bond market’s inflation gauge slides to lowest since Oct. 2017 as Fed meeting gets underway
Earnings Results: Micron shares drop as sales outlook falls $1 billion short of Wall Street target Earnings Results: Micron shares drop as sales outlook falls $1 billion short of Wall Street target
NewsWatch: Mnuchin thinks there’s a simple reason the Dow is poised for its worst December since 1931 NewsWatch: Mnuchin thinks there’s a simple reason the Dow is poised for its worst December since 1931

Leave a Reply

Submit Comment
© 2018 Stock Investors News. All rights reserved. XHTML / CSS Valid.